FBIO | NASDAQ

Fortress Biotech, Inc.

Fortress Biotech, Inc. (FBIO) | runway 12.6 months | financing risk lower | market cap $72.1M. Daily snapshot of financials, capital pressure, and recent dev...

Company websiteLast updated Apr 29, 2026

Share price

$2.22

As of Apr 29, 2026

Market cap

$72.1M

Snapshot valuation

30D volume

444,986 shares

Rolling average daily volume

Runway

12.6 months

Estimated from precomputed burn and cash

Financing risk

N/A

Current liquidity and recent financing activity do not point to an immediate capital raise.

Snapshot summary

Runway: 12.6 months based on estimated burn.

Recent financing detected on Feb 22, 2026.

Financing signal: Current liquidity and recent financing activity do not point to an immediate capital raise.

Recent developments

Fortress Biotech, Inc. 8-K 2026-03-31

8-K filed on 2026-03-31.

Mar 30, 2026, 8:00 PM

Fortress Biotech, Inc. 10-K 2026-03-31

10-K filed on 2026-03-31.

Mar 30, 2026, 8:00 PM

Fortress Biotech, Inc. 8-K 2026-03-30

8-K filed on 2026-03-30.

Mar 29, 2026, 8:00 PM

Fortress Biotech, Inc. 8-K 2026-02-23

8-K filed on 2026-02-23.

Feb 22, 2026, 7:00 PM

Fortress Biotech, Inc. 8-K 2026-01-13

8-K filed on 2026-01-13.

Jan 12, 2026, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures